News
Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate ...
The trial enrolled 49 patients with mTLS-negative STS, including leiomyosarcoma (45%) and synovial sarcoma (18%). The ...
Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging ...
When most people think of cancer, names like breast, lung, or prostate cancer instantly come to mind. However, there’s ...
Jennifer Rainey has spoken of her agony as her teenage daughter Eva has been diagnosed with sclerosing epithelioid ...
Despite its relative obscurity, this is one of the most aggressive and challenging cancers to diagnose and treat.
Sarcomas are cancers of the bits and pieces that put us together, like nerves, bones, blood vessels and fat cells ...
When most people think of cancer, names like breast, lung, or prostate cancer instantly come to mind. However, there’s ...
A MUM says her daughter’s back pain was the first sign before a diagnosis that would shatter the family. Eva Rainey, 16, has ...
From managing chronic conditions to preventive care and mental wellness, these expert insights offer simple, effective steps ...
A much-loved dog who was diagnosed with cancer has made a remarkable recovery after undergoing advanced surgery in Erith. Meadow, a 13-year-old springer spaniel, was diagnosed with a large soft tissue ...
5d
Stockhead on MSNHealth Check: Paradigm makes scenic acquisitive detour, but it’s no strategic shiftOsteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results